biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by KayakerBCon Jul 08, 2016 9:40am

141 Views

Post# 25034746

RE:RE:RE:RE:RE:RE:RE:RE:This is it.

LOL. Yes, now Jekyl Jr says he's "looking for our first real deal in the coming weeks."

He's saying all his blathering over the past month has been completely wrong. He previously said we don't have the data to get a money deal, BTI won't move until we get clinical data, that no pharmas are "sold" on the technology, and that nothing would happen this year.

Clown.

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!